In a study of patients on dialysis, investigators found no higher risk for retinal hemorrhages and other ophthalmic problems among roxadustat-treated patients compared with patients receiving ...
Investigators analyzed retinal hemorrhages and macular edema events in patients treated with roxadustat or darbepoetin alfa. The risk of developing ophthalmic abnormalities appears no higher with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback